10 &11 shock

33
Shock & RESUSCITATION Dr. haydar muneer B.D.S. , F.I.B.M.S.

Transcript of 10 &11 shock

Page 1: 10 &11 shock

Shock &

RESUSCITATIONDr. haydar muneerB.D.S. , F.I.B.M.S.

Page 2: 10 &11 shock

Define shock?

• Shock is a systemic state of low tissue perfusion, which is inadequate for normal cellular respiration. With insufficient delivery of oxygen and glucose, cells switch from aerobic to anaerobic metabolism. If perfusion is not restored in a timely fashion, cell death ensues.

Page 3: 10 &11 shock

Pathophysiology• Cellular• As perfusion to the tissues is reduced, cells are

deprived of oxygen and must switch from aerobic to anaerobic metabolism.

• The product of anaerobic respiration is not carbon dioxide but lactic acid. When enough tissue is underperfused, the accumulation of lactic acid in the blood produces systemic metabolic acidosis.

Page 4: 10 &11 shock

Pathophysiology• Microvascular• As tissue ischaemia progresses, changes in the

local environment result in activation of the immune and coagulation systems., resulting in the generation of oxygen free radicals and cytokine release. These mechanisms lead to injury of the capillary endothelial cells.

• Damaged endothelium loses its integrity and lead to tissue oedema

Page 5: 10 &11 shock

Classification of shock

1. Hypovolaemic2. Cardiogenic3. Obstructive4. Distributive5. Endocrine

Page 6: 10 &11 shock

Hypovolaemic shock

• Hypovolaemia is probably the most common form of shock

• Hypovolaemic shock is caused by a reduced circulating volume. Hypovolaemia may be due to haemorrhagic or non-haemorrhagic causes.

• Non-haemorrhagic causes include poor fluid intake

Page 7: 10 &11 shock

Cardiogenic shock

• Cardiogenic shock is due to primary failure of the heart to pump blood to the tissues.

• Causes of cardiogenic shock include myocardial infarction, cardiac dysrhythmias, valvular heart disease, blunt myocardial injury and cardiomyopathy

Page 8: 10 &11 shock

Obstructive shock• In obstructive shock there is a reduction in

preload because of mechanical obstruction of cardiac filling.

• Common causes of obstructive shock include cardiac tamponade, tension pneumothorax, massive pulmonary embolus and air embolus

Page 9: 10 &11 shock

Distributive shock

• Including Septic and anaphylaxis shock• Inadequate organ perfusionis accompanied by

vascular dilatation with hypotension• In anaphylaxis, vasodilatation is caused by

histamine release• The cause in sepsis is less clear but is related

to the release of bacterial products (endotoxins)

Page 10: 10 &11 shock

Endocrine shock• Endocrine shock may present as a

combination of hypovolaemic, cardiogenic and distributive shock.

• Causes of endocrine shock include hypo- and hyperthyroidism and adrenal insufficiency

Page 11: 10 &11 shock

Compensated shock

• As shock progresses the body’s cardiovascular and endocrine compensatory responses reduce flow to non-essential organs to preserve preload and flow to the lungs , brain and kidney.

• Patients with occult hypoperfusion (metabolic acidosis despite normal urine output and cardiorespiratory vital signs) for more than 12 hours have a significantly higher mortality rate, infection rate and incidence of multiple organ failure

Page 12: 10 &11 shock

Clinical features of shock

Page 13: 10 &11 shock

Compensated Mild Moderate Sever

Lactic acidosis

+ ++ ++ +++

Urine output

Normal Normal Reduce An uric

Level of consciousness

Normal Mild anxiety

Drowsy Comatose

Respiratory rate

Normal Increase increase Labored

Pulse rate Mild increase

Increase Increase Increase

Blood pressure

Normal Normal Mild hypotension

Sever hypotension

Page 14: 10 &11 shock

Consequences

Page 15: 10 &11 shock

Unresuscitatable shock

• Cell death follows from cellular ischaemia, and the ability of the body to compensate is lost.

• There is myocardial depression and loss of responsiveness to fluid or inotropic therapy.

• Peripherally there is loss of the ability to maintain systemic vascular resistance and further hypotension ensues.

Page 16: 10 &11 shock

Multiple organ failure

• is defined as two or more failed organ systems .There is no specific treatment for multiple organ failure. Management is by supporting organ systems with ventilation, cardiovascular support and haemofiltration/dialysis until there is recovery of organ function. Multiple organ failure currently carries a mortality rate of 60%.

Page 17: 10 &11 shock

 RESUSCITATION

Page 18: 10 &11 shock

• Immediate resuscitation manoeuvres for patients presenting in shock are to ensure a patent airway and adequate oxygenation and ventilation.

• Once ‘airway’ and ‘breathing’ are assessed and controlled, attention is directed to cardiovascular resuscitation.

• If there is initial doubt about the cause of shock it is safer to assume the cause is hypovolaemia and begin with fluid resuscitation

Page 19: 10 &11 shock

• Administration of inotropic or chronotropic agents to an empty heart will rapidly and permanently deplete the myocardium of oxygen stores and dramatically reduce diastolic filling and therefore coronary perfusion.

• First-line therapy, therefore, is intravenous access and administration of intravenous fluids. Access should be through short, wide-bore catheters that allow rapid infusion of fluids as necessary

Page 20: 10 &11 shock

• Vasopressor agents (phenylephrine, noradrenaline) are indicated in distributive shock states (sepsis, neurogenic shock), in which there is peripheral vasodilatation.

• Inotropic therapy may be required to increase cardiac output and, therefore, oxygen delivery.

Page 21: 10 &11 shock

There is no ideal resuscitation fluid

Page 22: 10 &11 shock

If blood is being lost, the ideal replacement fluid is blood, although crystalloid therapy may be

required while awaiting blood products.

Page 23: 10 &11 shock

Dynamic fluid response

• The shock status can be determined dynamically by the cardiovascular response to the rapid administration of a fluid bolus. In total, 250–500 ml of fluid is rapidly given (over 5–10 min) and the cardiovascular responses in terms

of heart rate, blood pressure and central venous pressure (CVP) are observed.

Page 24: 10 &11 shock

• Responders show an improvement in their cardiovascular status, which is sustained. These patients are not actively losing fluid

• Transient responders show an improvement but then revert to their previous state over the next 10–20 min. These patients either have moderate on-going fluid losses

• Non-responders are severely volume depleted and are likely to have major on-going loss of intravascular volume.

Page 25: 10 &11 shock

Monitoring for patients in shockMinimum1. Electrocardiogram2. Pulse oximetry3. Blood pressure4. Urine output

Page 26: 10 &11 shock
Page 27: 10 &11 shock
Page 28: 10 &11 shock
Page 29: 10 &11 shock

Monitoring for patients in shockAdditional modalities1. Central venous pressure2. Invasive blood pressure3. Cardiac output4. Base deficit and serum lactate base deficit over 6 mmol

Page 30: 10 &11 shock
Page 31: 10 &11 shock
Page 32: 10 &11 shock

Endpoints of resuscitation

• It is much easier to know when to start resuscitation than when to stop

• Resuscitation algorithms directed at correcting global perfusion endpoints (base deficit, lactate, mixed venous oxygen saturation) rather than traditional endpoints in order to avoid occult hypoperfusion (OH).

Page 33: 10 &11 shock